skysight-inc/HackerNews huggingface dataset:
Sorry for linking to a cut-and-paste site, but the FT's syndication model is rather a nuisance. The original story is at

http://www.ft.com/cms/s/0/b0a854f8-6a1b-11e1-a26e-00144feabd...

has title "In search of outside inspiration", and has Chris Bryant's byline.
Perl 6 will have a Perl 5 compatibility mode. Yes, it's a more ambitious effort and it's a loose analogy. However, I don't think there's a need to have both Perl 5 and 6. It's meant as an evolution to solve the same kinds of problems. Perl 5 came back to life after it became clear Perl 6 was going to take even longer, and it's adding some of the improvements from Perl 6.

Anyway, the observation is to note how long it takes to get people "upgrade" when "breaking" changes are made to languages.
"Error establishing a database connection"

Any mirror ?
You could have an obvious way to click the images and go to the big size (maybe in a lightbox?)
New England Jersey
Our soccer jerseys online shop provides a broad selection of the latest England Soccer Jersey at competitive prices. The England Football Shirt will make you achieve the envy of other soccer fans. You can find your favorite New England Jersey here for your favorite teams.
I think both of these companies have lost sight of why these websites even exist in the first place. A trait that is not limited to these two companies alone... I'm looking forward to new innovation the future brings, because IP battles like this are starting to looking like crackheads fighting over the last rock.
Mine says that they own anything that's related to their business. If I tried to write a competing product, or work for a competitor, they'd own my work.

I felt that was perfectly valid and accepted it. There have been a few things that I felt were grey areas, and I've just decided not to work on them. I have plenty of other things, and they weren't money-makers anyhow.
Using Facebook JS SDK with Ember.js
I don't see any reason why I must do all this extra stuff. When there are better alternatives available elsewhere.
Reminds me fondly of Karl Sims 91 paper. It gives an impression of what should be possible with relatively simple expressions:

http://www.karlsims.com/papers/siggraph91.html
also don't forget that for these companies the poor people in India are the subjects of clinial trials.

The mindset of these companies of treating the poor people as Guinea pigs is also disgusting

671 reported deaths http://www.business-standard.com/india/news/human-rights-pan...

There is no count of no of people who get disabilities but don't die due to trials failing. Who will pay for these? These pharma companies are steered by greed
I don't think Python community ~ Django community; I do believe the loudest elements in any geek community are, invariably, web developers, who (unsurprisingly) are over-represented on the web. Once you satisfy them, the level of noise on any given subject drops considerably.

At the moment, they are pissed off that Django is not moving as fast as the language, so they whine that "nobody is moving to Python 3". As soon as that's fixed, the noise will drop.

Same for the numpy/scipy community, which is the other big one for Python. Lots of academic people there, who have a lot of spare time to bitch on the web.
Perhaps the FDA should bankroll clinical trials, subject to a pre-agreed price and a reasonable case that the trial will work out. Monopoly sellers and monopoly buyers is fairer than a monopoly seller.
Make a JavaScript getter act both as getter and as a function
I am referring to FDA trials, in the US, which can take over a decade and cost 8- or 9-figure dollar sums. These are required before the drug even comes to market.
And yet, according to: http://www.raspberrypi.org/archives/509

"If a British company imports components, it has to pay tax on those (and most components are not made in the UK). If, however, a completed device is made abroad and imported into the UK – with all of those components soldered onto it – it does not attract any import duty at all. This means that it’s really, really tax inefficient for an electronics company to do its manufacturing in Britain"
You seem very poorly informed about the subject. While I don't agree with the vast amount of lobbying a lot of pharma companies do, which in itself increases costs, the costs of R&D and the process of approval are huge.

Get rid of drug patents, bye bye new drugs without direct g'vmt funding. Drugs are trivial to reverse engineer, incredibly expensive to invent.

There is also a massive amount of drugs that go nowhere, often even failing at major trail stage, so the successes pay for the failures.
From Dabbling to Shipping Successful Software
Those costs could be covered by the government in this case and they should increase the investment to match all money lost on dead end R&D and add standard going rate profits on top - on the grounds that it is a market failure of public good - R&D. Also the costs will be covered in the richer markets. I'm no fan of government interventions but the fact that we are having a debate around intellectual property shows how dire things are.
Don't have a mirror handy, but here's the markdown for the post (minus some edits I did on the site for clarity): http://pastie.org/3584715
You've forgotten the role conflicts can play in birthrates, for example to ensure one group remains dominant. [1]

[1] https://en.wikipedia.org/wiki/Demographic_threat
> But the thing is that the people criticizing are (a) providing zero direct support to the homeless

I am.

But I did say that many people are too quick to complain. (I appreciate my wording was not good.)
Show HN: JSFace a small footprint, elegant, powerful, cross platform OOP library
> Investors will be placing their bets on who they believe has the better legal standing and lawyers in this new patent war

Surely investors will be placing their bets on what the minimum amount of money that Yahoo! will take to go away and get out of the way of the IPO.

Or have people been living under a rock and actually think that legal standing and lawyers make the slightest difference in resolving patent battles of this sort?
Barack Obama does the same thing.
Yes, it would be great if the Indian govt financed research into new medicines. India already makes a lot of the world's generic drugs. They could move up market and actually create new drugs. A win-win for [just about] everyone. Perhaps fund one of the IIT's and have it work with industry.
So the fact that the source isn't there is proof that copyright prevented it? I may have a tiger repellent rock to sell you.

You need to provide evidence that the source of the Mac OS, Oracle or DB2 would be there if copyright didn't exist.
Fact: The Agile movement is a marketing stunt from 3M #arthurfryday
me too. Maybe the op can change the title to also include the "good news!" part. When I first saw the title I was actually expecting some bad news.
Wow, that's really awesome; hadn't seen that before. While it's not nearly at that level yet, I'd love to get to the point where I'm generating content as nice as he managed to. Hopefully once I get the genetic algorithm attached I'll start seeing some magic happen.
Simple CMS to be bolted on to existing site
I don't need years of battery life: I need 32-36 hours (of use, not standby). Then I can go from charging daily, like in the nineteenth century where you have to wind your watch up every night, and Sherlock Homes can tell a watch belonged to a drunkard by scratches around where you insert the winding key; how different is it to fumble with the power adapter jack? - ahem, to charging whenever it is CONVENIENT for me. It still wouldn't quite last through a long weekend at a lodge with just one inconvenient power outlet if you use it a lot EVERY day, but most people don't and if you do, you still only have to find a quiet period to charge it ONCE during the long weekend, like whenever the social activity dies down.

How many people keep multiple chargers at the different places (home/office) they are, or even take one with them ALL the time, just so they don't get left stranded. All this is fixed if the machine has a longer cycle than you do, over a typical 1-2 day cycle. Then you can pick the most convenient time to charge up from 20 or 40 or 60 percent or wherever it's at by then, you can work on it it at a cafe without plugging it in after working somewhere else you couldn't plug it in the night before, or go away for the weekend with it without any charger at all, if you know you're back in the ofice Monday and are sure to use it less than that.

In the meantime you don't worry, you aren't inconvenienced.
These macros are nothing compared to what I consider a real abuse of the preprocessor - a whole functional language implemented just by that! Search for "chaos-pp" in this entry (which has plenty of other wonders too!):

http://stackoverflow.com/questions/652788/what-is-the-worst-...
In case of Nexavar, another company is able to manufacture far more cheaply and that says something about Bayer. Either they are unable to manufacture cheaply or they are unwilling to price it cheaper.

Suppose that big pharma stops selling drugs in India. That wouldn't make much difference because the generic drug manufacturers would still make cheap copies of the drugs. The only downside would be that new drugs will take time to be introduced because of the time needed to reverse engineer the formulae and set up manufacturing capabilities.
I'm a frontend developer and I think some of these expectations make little sense. Giving a name to every layer is a lot of work and I don't care about it that much. I'll do my work with layers like "Layer 0 copy copy" as long as they're grouped. Having designer rename all the layers is a lot of work that would be better spent creatively. (Does your boss want to pay the designer for it?)

Another example: "#34 Be familiar with browser compatibility" - this is just your, developer's job. I cannot imagine expecting a designer to know about IE6 limitations (and tons of hacks and techniques to overcome them).

That said, I agree with many points, like naming files properly (which costs almost nothing) or careful use of blending modes (which are a lot of pain for the developer). Or careful use of gradients, especially over repeating patterns (#22).
This would result in:

(1) the FDA regulating access, pricing, and financing to the pharmaceutical industry, effectively nationalizing it, and,

(2) the US effectively bankrolling pharma for the rest of the world (it does this to a large extent already, but this would throw the scales all the way).

It would also have little effect on what innovator (or generic, for that matter) drug companies could charge outside the US.
眼袋怎么消除
Unlocked Samsung Galaxy S3 can be preordered for 800$
They already did the overwhelming majority of the work. Developing that kind of stuff is expensive. I've seen estimates of ~100MM USD quoted for the discovery of a new drug.
Look at the availability of Linux source code compared to Mac OS X. It's everywhere.

In terms of proof and evidence, no one can really "prove" anything without actually experiencing the counterfactual world. You can't prove that MacOS X code would not be everywhere, for instance, just as I can't prove that it would be.

The best we can do is look for evidence that suggests how things might go.
I think they just want to add more coupling between the two platforms. Sure enough, Twitter could write such a platform on their own but perhaps it's more time-efficient to just buy legacy technology and adapt it. Even more so when you get the staff who built the said technology along with it.

Another aspect is the user-base that will come with Posterous.
Difference between Polymorphism vs Overriding vs Overloading
Covering bad R&D deadens the incentive for firms to do R&D efficiently - it's structurally identical to the implicit guarantees that are proving so problematic in finance.
Check out the example in the first answer :D
The reason why it's expensive to develop drugs is in large parts because of the process involved to get the approval.

Couldn't you turn this on it's head?

What if the companies could expense the cost of getting the approval. I.e. the tax payers pay for drugtesting and approval process.

Wouldn't this make sense? Since it's in the publics interest to get safe medicin, shouldn't they/we pay for that part.
By artificially limiting the number of invites, you get a finite number of individuals to work with and get feedback from during your beta.

I'm not sure the referrals program is always the solution you want. You should try to make sure the people who are coming to your site are qualified, otherwise Joe will ask Alice, Bob, and Charlie to join. Those 3 won't stay for any meaningful amount of time (blowing 3 of your slots), and Joe now has upgrades/perks/???. It's more desirable for you to have those 3 users giving you input.

However, there could be a time when you don't want to limit invites, such as when you need user generated content. Then the more beta users you have, the more content you have generated when you go "live".
What You Sell and What They Buy
All Major Browsers Pwned
The problem is that the govt is providing an artificial barrier to entry by other companies which protects the profits of the big pharma. Because of it the pharma companies have no incentive to reduce prices . They would rather spend the money on lobbying
It may also depend on which part of the world you are in...
Judging from the video, the resolution / dot size is about 1 µm (one micrometre). For comparison, the thickness of the tape in a 120-minute compact cassette is 9 µm, the diameter of a typical bacterium is 1–10 µm, and the diameter of the nucleus of a typical eukaryotic cell is 7 µm (http://en.wikipedia.org/wiki/1_micrometre).
> what a disappointing step for Y!'s new CEO to take

Given the timeframe, I don't think the new CEO had the time to pull that off.
Transcription Services
Google sometimes attaches patent licenses for non-aggressors for code they've open-sourced (see: WebM). That ties the hands of a future management: the relevant patents are only useful defensively. Anyone not suing Google (or a downstream user of Google's code) for patent infringement related to that code can take advantage of the freely available patent license.

Of course, they're not doing that for everything (e.g. PageRank patents), but to the extent that they do this for the patents they intend to use defensively, they might avoid this problem.
You risk everybody threwing some shit into the pipeline. Now they have to think about if the really want to trie to get it threw.
My guess is that this is not so much about saving patients from cancer than it is about saving polititians during the next elections.
ARM employs about 2 000 people [1]. They're definitely a huge boon for the British tech community and competitiveness, but justifying government support for such a small employee base would be untenable.

[1] http://www.arm.com/about/company-profile/index.php?setcookie...
Do you go back and refactor #promoCol to .promoCol?

Yeah, that's exactly what you do. Just because your new dev doesn't know how to refactor (and it's hardly even refactoring, it's like a two-line diff) doesn't mean we all shouldn't use IDs.

IDs have an extra bit of self-documentation when you use them - when I see #promoCol, I know instantly that there's just one promocol, and I don't have to worry about breaking the look of another promocol while I'm fiddling with the CSS in there. If there's a class, you don't know how many things it applies to until you've done a grep over your project.
You may also like Lindenmayer Systems and Context-Free-Grammars (http://www.contextfreeart.org/ )

I always thought a proper CF renderer (or StructureSynth http://structuresynth.sourceforge.net/ (my own efforts: https://sites.google.com/site/williamedwardscoder/home/exten... )) would make a great JS1K entry :)
Nobody reading HN is in the target audience for this book.

However, we probably have acquaintances and relatives who could benefit.
Digital storytelling on the grid
I don't see any reason why I must do all this extra stuff

You don't have to do all this extra stuff. You could say I'm going with python3 and simply live without (or port or re-implement) any features from third party libraries that don't have a python2 version. Or you could say I'm going with python2 and live with the facts that the language won't be evolving any more and a few years from now most libraries will only see updates to their python3 branch. Both of those approach are also perfectly reasonable depending on the scope of the project.

When there are better alternatives available elsewhere.

Obviously if there are significantly better answers than python to the problem you're facing then you should be using one of those alternatives. I was assuming that you'd already decided that python was the best fit for an upcoming project and needed a plan on how to proceed.
...but aren't Yahoo in bed with Microsoft... who are one of the largest share holders of Facebook?
Electric and Lighting
FYI its impossible to read on an iPhone, since the sidebar blocks the view. I tried to click the buttons on top, since they like close/hide buttons, but no reaction.
I am not sure I follow?

It would force the governments to develop better and cheaper systems themselves to make sure that they can test for cheap.

Surely the current scenario isn't working is it?
Redirect this!
Quality Led Controllers and Led Flex Strips
If you are looking for quality led lights, led bulbs. We provide latest led controllers, led flex strips and led streetlights. For more details, please visit our website.
Create gorgeous ‘portable’ websites with Sidengo
Yahoo Crosses The Line
>> however because of such decisions companies will find it risky to invest in life saving drug research.

I disagree. That mentality is precisely the reason that they are overpricing now (and always have done so) as much as they can. People will always need life saving drugs, and ordinary drugs as well. Terminal and cronical patients will always try both traditional and new drugs (or the state will provide it to them in case there is health care). There is absolutely no need to overprice because any price will eventually give a fair ROI for them.

What they do instead is maximize profit at the cost of human life.

On a different light, a lot of research is funded by government entities worldwide, and even if pharmaceutical companies do their own research, they certainly reference other research that is also publicly funded. Thankfully some states do care a lot about their people and will challenge them. India is doing so now, Brazil has also broken HIV drug patents (they cover the full cost of treatment through Health Care) and I hope to hear more of it from different places.
Thanks a lot for these. I know of Context Free but had no idea about StructureSynth. I sense a WebGL port in the very near future.
U.S. Patent No.7,406,501
System and method for instant messaging using an e-mail
protocol

Abstract
Systems and methods allowing an instant messaging user to exchange messages with an e-mail user.
To the instant messaging user, the experience is a seamless exchange of instant messages; to the
e-mail user, the experience is a seamless exchange of e-mail messages. Conversion of an instant
message to an e-mail message includes insertion of a token into the e-mail message, and conversion
of an e-mail message to an instant message includes validating a token extracted from the e-mail
message.

It looks like GMail is also infringing that patent.
It felt more like a lifetime to me!
"this is just your, developer's job"

Shockingly, it's not. Most places I know of are moving away from a the designer and frontend developer positions. It's a big cost savings, not just in salary but in cycle time as well. Our designer sends us his designs in HTML. There is no bickering over fonts, no pixel perfection, no stupid photoshop-isms -filters, drop shadows, embossing, etc. I'm pretty sure he doesn't even have photoshop.

If you're a web designer and you can't do this, it's time to learn. You're a theoretical web designer drawing pictures of websites.
Yep. I don't even use/like Facebook, but I just deleted my 10 year old Yahoo account in protest (in truth it was only a secondary account after Google, but still).
So if the businesses make no more money how will the invest in R&D for new medication? Im not advocating pure capitalism but businesses have to make some profit.

I agree that the more socialsist systems work better atm but this does not include development of new medication and equipment. Would you want that in gov hands too?
I always find it funny that they force the legit users to sit through all that rubbish, having paid good money to watch the movie, yet the pirates skip through all that. I particularly hate the DVDs that force me to watch the trailers for upcoming releases. Come on, if I wanted to watch trailers then I'd go to the cinema! :)
I worked in the drug R&D business for over 8 years. I still follow the industry closely. Some things always get lost in these discussions. First, manufacturing an existing drug is absurdly cheap. Modern industrial chemistry ensures this for all small molecule drugs (note that this is not the same case for the "biologics" which are often fiendishly difficult to make). Almost all the cost in a drug is the manufacturer recouping R&D costs. These costs have been spiraling out of control for 10 years. They are astronomical. A recent Forbes analysis pegs the cost of a new drug with failures of drugs in development folded in anywhere from $3 billion to $12 billion depending on the manufacturer (excellent context and discussion here: http://pipeline.corante.com/archives/2012/02/10/the_terrifyi...).

You don't need to be an industry expert to grok that those numbers are wildly unsustainable. It is not possible to keep spending the amount companies spend to make new drugs. In the past, companies would inflate the price in the USA to make up for reduced prices elsewhere. But with all the recent healthcare reform in the USA, that strategy is ending.

To add insult to injury, the vast majority of the most commonly used drugs will lose patent protection in the next couple of years. In the industry they call this the patent cliff. There will not be enough new drugs to offset all the ones that go generic.

This move by India is a symptom of the wider drug industry problems. There will be more of these kinds of moves in the future. The industry has been searching for ways to more effectively make drugs and have it not be so expensive. But so far they have been striking out for 10 years running. The current strategy is to lay off most of their r&d workforce and offshore and outsource this part of the business.

Somewhere out there, a business model is waiting to be found. Whoever cracks that nut and becomes the Southwest of the drug industry is going to make a fortune.
The Future Belongs to the Curious [video]
I need some British money.

Failing that, some Nyan Cat money!
What I was trying to say: When the goverments pays for testing how will you stop brute force testing?

> It would force the governments to develop better and cheaper systems themselves to make sure that they can test for cheap.

I doute they cool do that.

> Surely the current scenario isn't working is it?

Well like most things it kind of works but is not very effective.

I agree its not very good right know but I don't know how to change it.
It happened on his watch - something this big definitely had his stamp on it.
UN torture chief rules: Bradley Manning's treatment was cruel and inhuman
No, the designer has to know the medium he or she designs for.

If you don't understand the medium, you basically create pretty pictures. That's about it.

It's no different from designing newspapers, brochures, fashion.
Their actions just show how desperate they are. Bye bye Yahoo! and thanks for the fish.
Well, they hold under 2% as far as I know.
DIY “Internet of Things” Camera
My pleasure. I think personal well-being is important if you want to be productive in any field.